What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Her primary scientific interests are in Prostate cancer, Prostate, Pathology, Internal medicine and Prostatectomy.
Her Prostate cancer research incorporates elements of Carcinogenesis, Biopsy, Odds ratio and Gynecology.
Her Prostate study incorporates themes from Cancer research, Standardized uptake value and Gene expression.
Isabell A. Sesterhenn interconnects Intraepithelial neoplasia, Radiology and Adenocarcinoma in the investigation of issues within Pathology.
Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Oncology.
The various areas that Isabell A. Sesterhenn examines in her Prostatectomy study include Nuclear medicine, Confidence interval, Prostate biopsy, Stage and Primary tumor.
Her most cited work include:
- The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
- The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder (1309 citations)
- Bladder cancer: Epidemiology, staging and grading, and diagnosis (634 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Prostate cancer, Pathology, Prostate, Internal medicine and Cancer research.
In general Prostate cancer, her work in Prostatectomy and PCA3 is often linked to TMPRSS2 linking many areas of study.
Her work investigates the relationship between Pathology and topics such as Embryonal carcinoma that intersect with problems in Testicular cancer.
Her research in Prostate intersects with topics in Gene expression, Urology, Radiology and Adenocarcinoma.
Her research integrates issues of Endocrinology and Oncology in her study of Internal medicine.
Her study in Cancer research is interdisciplinary in nature, drawing from both Carcinogenesis, Gene, Immunology, LNCaP and Androgen receptor.
She most often published in these fields:
- Prostate cancer (61.65%)
- Pathology (48.67%)
- Prostate (44.54%)
What were the highlights of her more recent work (between 2013-2021)?
- Prostate cancer (61.65%)
- Internal medicine (35.69%)
- Oncology (27.73%)
In recent papers she was focusing on the following fields of study:
Prostate cancer, Internal medicine, Oncology, Prostate and Cancer research are her primary areas of study.
Her Prostate cancer research integrates issues from Biopsy and Pathology.
Her work on Malignancy as part of general Pathology study is frequently connected to World health, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Internal medicine research includes elements of Endocrinology, Gynecology, Germline and Single-nucleotide polymorphism.
Her Oncology research focuses on subjects like Metastasis, which are linked to Tumor Status.
Her biological study spans a wide range of topics, including Immunohistochemistry, Radiology, Gene expression and Disease.
Between 2013 and 2021, her most popular works were:
- A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer. (186 citations)
- A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men (38 citations)
- Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score (32 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Isabell A. Sesterhenn mostly deals with Prostate cancer, Internal medicine, Oncology, Prostate and Pathology.
When carried out as part of a general Prostate cancer research project, her work on Androgen receptor is frequently linked to work in TMPRSS2, therefore connecting diverse disciplines of study.
Her Internal medicine study combines topics in areas such as Endocrinology, ATF6 and Programmed cell death.
Isabell A. Sesterhenn combines subjects such as Prostatectomy, Biochemical recurrence, Case-control study and Receiver operating characteristic with her study of Oncology.
Isabell A. Sesterhenn studied Prostate and Biopsy that intersect with Urine, PCA3 and Rectal examination.
Her Pathology study combines topics from a wide range of disciplines, such as Prostate-specific antigen and LNCaP.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
